CURLF · OTC · CIK 0001756770
Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc.’s most recent SEC filing in our snapshot is a Form 425 filed on Oct 19, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $1.3B and net income of -$231.1M, according to its XBRL data on EDGAR. Its EDGAR record lists 0 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- Curaleaf Holdings, Inc.
- Ticker
- CURLF
- SEC Central Index Key (CIK)
- 0001756770
- Industry (SIC)
- Medicinal Chemicals & Botanical Products (code 2833)
- Business address
- STAMFORD, CT
- State or country of incorporation
- British Columbia, Canada
- Fiscal year ends
- December 31
- SEC filer category
- Large accelerated filer
- Position in SEC ticker list
- #1929 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from Curaleaf Holdings, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.3B | $1.3B | $1.3B | $1.3B |
| Net income | -$205.9M | -$370.1M | -$281.2M | -$215.4M | -$231.1M |
| Diluted EPS | -$0.29 | -$0.52 | -$0.39 | -$0.32 | -$0.35 |
| Total assets | $3.1B | $3.4B | $3.1B | $2.9B | $2.8B |
| Cash and equivalents | $299.3M | $163.2M | $91.8M | $107.2M | $101.6M |
XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Aug 6, 2026 | 10-Q | 6-K· period Jun 30, 2026 | Document · Index |
| Oct 19, 2026 | 8-K | Other events· period Oct 19, 2026 | Document · Index |
| Aug 3, 2026 | 6-K | Report of a foreign private issuer· period Aug 3, 2026 | Document · Index |
| Feb 27, 2026 | 40-F | Annual report of certain Canadian issuers· period Dec 31, 2025 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about Curaleaf Holdings, Inc., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 19, 2026 | 425 | 425 | Document · Index |
| Oct 19, 2026 | 8-K | Other events· period Oct 19, 2026 | Document · Index |
| Oct 6, 2026 | 425 | 425 | Document · Index |
| Oct 6, 2026 | 8-K | Other events· period Oct 6, 2026 | Document · Index |
| Oct 6, 2026 | F-X | F-X | Document · Index |
| Oct 6, 2026 | SC14D1F/A | SC14D1F/A | Document · Index |
| Oct 6, 2026 | 425 | 425 | Document · Index |
| Oct 6, 2026 | 8-K | Other events· period Oct 6, 2026 | Document · Index |
| Oct 6, 2026 | F-80 | F-80 | Document · Index |
| Oct 5, 2026 | 8-K | Director or officer change· period Sep 28, 2026 | Document · Index |
| Oct 1, 2026 | 8-K | Regulation FD disclosure· period Sep 29, 2026 | Document · Index |
| Oct 1, 2026 | 8-K | Regulation FD disclosure· period Sep 23, 2026 | Document · Index |
| Sep 16, 2026 | 8-K | Other events· period Sep 16, 2026 | Document · Index |
| Sep 16, 2026 | 425 | 425 | Document · Index |
| Sep 15, 2026 | 425 | 425 | Document · Index |
| Sep 15, 2026 | 8-K | Other events· period Sep 15, 2026 | Document · Index |
| Sep 14, 2026 | 425 | 425 | Document · Index |
| Sep 14, 2026 | 8-K | Other events· period Sep 14, 2026 | Document · Index |
| Sep 8, 2026 | 8-K | Other events· period Sep 8, 2026 | Document · Index |
| Sep 8, 2026 | 425 | 425 | Document · Index |
| Sep 2, 2026 | 425 | 425 | Document · Index |
| Sep 2, 2026 | 8-K | Other events· period Sep 2, 2026 | Document · Index |
| Aug 27, 2026 | SC14D1F/A | SC14D1F/A | Document · Index |
| Aug 25, 2026 | 425 | 425 | Document · Index |
| Aug 25, 2026 | 8-K | Other events· period Aug 24, 2026 | Document · Index |
| Aug 18, 2026 | 425 | 425 | Document · Index |
| Aug 18, 2026 | 8-K | Other events· period Aug 18, 2026 | Document · Index |
| Aug 18, 2026 | SC14D1F | SC14D1F | Document · Index |
| Aug 18, 2026 | F-X | F-X | Document · Index |
| Aug 18, 2026 | F-80 | F-80 | Document · Index |
| Aug 13, 2026 | 425 | 425 | Document · Index |
| Aug 12, 2026 | 8-K | Other events· period Aug 11, 2026 | Document · Index |
| Aug 6, 2026 | 8-K | Other events· period Aug 5, 2026 | Document · Index |
| Aug 6, 2026 | 8-K | Results of operations· period Aug 5, 2026 | Document · Index |
| Aug 6, 2026 | 10-Q | 6-K· period Jun 30, 2026 | Document · Index |
| Aug 3, 2026 | 6-K | Report of a foreign private issuer· period Aug 3, 2026 | Document · Index |
| Jul 21, 2026 | 6-K | Report of a foreign private issuer· period Jul 15, 2026 | Document · Index |
| Jul 14, 2026 | 6-K | Report of a foreign private issuer· period Jul 13, 2026 | Document · Index |
| Jul 14, 2026 | 6-K | Report of a foreign private issuer· period Jul 10, 2026 | Document · Index |
| Jul 8, 2026 | 6-K | Report of a foreign private issuer· period Jul 6, 2026 | Document · Index |
Insider filing activity
0 Form 4 filings appear in Curaleaf Holdings, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Medicinal Chemicals & Botanical Products
- RGC Regencell Bioscience Holdings Ltd
- DFTX Definium Therapeutics, Inc.
- TRLV Trulieve Cannabis Corp.
- CRON Cronos Group Inc.
- RAJAF TFA Therapeutics, Inc.
All 6 companies in Medicinal Chemicals & Botanical Products· Companies headquartered in Connecticut
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001756770 and XBRL company facts. Curaleaf Holdings, Inc. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement